Literature DB >> 20937668

Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells.

Akira Nabetani1, Fuyuki Ishikawa.   

Abstract

Unlimitedly proliferating cells need to acquire the telomere DNA maintenance mechanism, to counteract possible shortening through multiple rounds of replication and segregation of linear chromosomes. Most human cancer cells express telomerase whereas the other cells utilize the alternative lengthening of telomeres (ALT) pathway to elongate telomere DNA. It is suggested that ALT depends on the recombination between telomere repetitive DNAs. However, the molecular details remain unknown. Recent studies have provided evidence of special structures of telomere DNA and genes essential for the phenotypes of ALT cells. The molecular models of the ALT pathway should be validated to elucidate recombination-mediated telomere maintenance and promote the applications to anti-cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937668     DOI: 10.1093/jb/mvq119

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  36 in total

Review 1.  Telomere Length Maintenance and Cardio-Metabolic Disease Prevention Through Exercise Training.

Authors:  Joshua Denham; Brendan J O'Brien; Fadi J Charchar
Journal:  Sports Med       Date:  2016-09       Impact factor: 11.136

2.  Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma.

Authors:  Sven Lindner; Hagen S Bachmann; Andrea Odersky; Simon Schaefers; Ludger Klein-Hitpass; Barbara Hero; Matthias Fischer; Angelika Eggert; Alexander Schramm; Johannes H Schulte
Journal:  Biomed Rep       Date:  2015-05-13

Review 3.  Maintaining the end: roles of telomere proteins in end-protection, telomere replication and length regulation.

Authors:  Jason A Stewart; Mary F Chaiken; Feng Wang; Carolyn M Price
Journal:  Mutat Res       Date:  2011-09-17       Impact factor: 2.433

4.  Alternative lengthening of telomeres: recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction.

Authors:  Despoina Sakellariou; Maria Chiourea; Christina Raftopoulou; Sarantis Gagos
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

5.  The human CTC1/STN1/TEN1 complex regulates telomere maintenance in ALT cancer cells.

Authors:  Chenhui Huang; Pingping Jia; Megan Chastain; Olga Shiva; Weihang Chai
Journal:  Exp Cell Res       Date:  2017-03-31       Impact factor: 3.905

6.  Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers.

Authors:  Meng-Hsun Hsieh; Cheng-Hui Tsai; Chuan-Chuan Lin; Tsai-Kun Li; Ting-Wei Hung; Li-Te Chang; Ling-Wei Hsin; Shu-Chun Teng
Journal:  Cell Mol Life Sci       Date:  2014-11-28       Impact factor: 9.261

7.  Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations.

Authors:  Ahsan S Farooqi; Rebecca A Dagg; L Mi Rim Choi; Jerry W Shay; C Patrick Reynolds; Loretta M S Lau
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

8.  Caenorhabditis elegans POT-2 telomere protein represses a mode of alternative lengthening of telomeres with normal telomere lengths.

Authors:  Chen Cheng; Ludmila Shtessel; Megan M Brady; Shawn Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

Review 9.  miR-221/222: promising biomarkers for breast cancer.

Authors:  Wei-Xian Chen; Qing Hu; Man-Tang Qiu; Shan-Liang Zhong; Jin-Jin Xu; Jin-Hai Tang; Jian-Hua Zhao
Journal:  Tumour Biol       Date:  2013-03-27

10.  The roles of telomerase in the generation of polyploidy during neoplastic cell growth.

Authors:  Agni Christodoulidou; Christina Raftopoulou; Maria Chiourea; George K Papaioannou; Hirotoshi Hoshiyama; Woodring E Wright; Jerry W Shay; Sarantis Gagos
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.